About Vita 34

We protect your child's stem cellswork

Vita 34 is one of the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells. It was founded in 1997 by immunologist and Dr. med. Eberhard Lampeter. He saw the opportunities that stem cells could afford us and became a pioneer in the field of umbilical cord blood storage. Since 2015 Vita 34 has been operating and collecting stem cells in the Nordic region, after having acquired the Danish stem cell bank StemCare. .

The purpose of Vita 34’s work is to provide access to new products or therapies on the basis of stem cells to all people."

Dr. André Gerth (CEO)

Experienced chemists, biologists, biotechnologists, specialized physicians, midwives and professional medical/technical assistants have made Vita 34 what it is today. For 20 years we have not only been storing umbilical cord blood, but also set standards with our experience, research and innovations.

Vita 34 has a solid team of dedicated employees, whom you can meet here.
In addition to our permanent staff, we employ approximately 35 midwives, nurses and laboratory technicians, who work for us in the Nordic region.

Since the foundation in 1997, the company has constantly advanced. Employees and management all share their belief in progress and innovation in stem cell therapy, which bears enormous medical potential. Vita 34 wants to participate actively in shaping this development.

Vita 34 has its own innovation division of research and development, which contributes essentially to innovations being lived and realized in the company. Innovation processes at Vita 34 are characterized by particularly target-oriented and detailed development. In the course of researching and establishing new therapies in the field of regenerative medicine, stem cells are gaining more and more importance.

From a German cord blood bank to an internationally acting business – that describes the development of Vita 34 in the past years. With the help of cooperation partners and means of acquisitions, Vita 34 continuously opens up new attractive markets in Europe and beyond.